Optison Injection, Solution
Product Images NDC 0407-2707

2 FDA label images from Ge Healthcare Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Optison (NDC 0407-2707). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ge Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Optison 01)

Chemical Structure (Optison 01)
Chemical structure of Perflutren, the active ingredient in Optison Perflutren Protein-Type A Microspheres injection. The diagram shows the fluorinated hydrocarbon molecular configuration.*
FDA Label Image

Principal Display Panel (3 mL Vial Carton Label)

Principal Display Panel (3 mL Vial Carton Label)
Label for Optison Perflutren Protein-Type A Microspheres Injection, a 3 mL vial solution for intravenous use. The label states it contains 18 vials of 3 mL each, with detailed storage instructions and protein microsphere composition. Manufactured by GE Healthcare Inc., the label includes NDC 0407-2707-18, lot, expiration, barcode, and product origin information from Norway.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.